Pennsylvania health officials reported the state’s sixth measles-associated death, as one-in-five infections has required hospitalization.


RT’s Three Key Takeaways:

  1. Escalating Outbreak Impact: The Pennsylvania Department of Health confirmed a sixth measles-associated death in 2026, with cumulative statewide cases reaching 1,467 across 45 counties.
  2. Severe Pulmonary Complications: Nearly 20% of identified patients have required inpatient hospitalization, with the airborne virus posing substantial clinical risks for acute respiratory illnesses such as pneumonia.
  3. Infection Control and Immunization: Less than 1% of confirmed cases occurred among vaccinated individuals, prompting state officials to recommend an early dose of the measles, mumps, and rubella vaccine for infants in high-transmission areas.


An unvaccinated resident of Jefferson County, Pennsylvania has died following a confirmed measles infection, marking the sixth measles-associated fatality in the state this year, according to the PA Department of Health (DOH).

The death was formally reported to the CDC as the state continues to track an ongoing outbreak that has grown to 1,467 confirmed cases across 45 counties. Statewide surveillance data show that 283 patients have required hospitalization, highlighting the acute burden the infection can place on inpatient and pulmonary healthcare resources.

According to DOH data, confirmed measles-associated fatalities in 2026 include three residents from Lancaster County, two from Jefferson County, and one from Mifflin County. Under the agency’s epidemiological case definition, a confirmed measles-associated death must occur within 30 days of symptom onset in an individual with clinical evidence of infection and a positive laboratory test, without an unrelated primary cause. DOH noted that an additional reported death involving a Franklin County resident in October is under investigation and has not met the confirmation criteria to date.

The department reported 34 newly confirmed cases across the commonwealth over a two-day span, while emphasizing that only five cases—less than 1% of the total—have occurred among vaccinated individuals.

Clinical Considerations for Respiratory Care Teams

Measles is an airborne pathogen spread when an infected person breathes, coughs, or sneezes, with viral particles remaining viable in airspace and on surfaces for up to two hours after an infected individual departs, according to DOH. Initial symptoms typically present with fever, cough, coryza, and conjunctivitis, followed by a descending rash. Patients are contagious approximately four days before to four days after rash onset.

In its clinical advisory, DOH warned that the virus can lead to severe pulmonary and neurological sequelae, including pneumonia and encephalitis. While fatal outcomes generally range between one and three deaths per 1,000 cases, inpatient intervention has been required in nearly 20% of Pennsylvania cases during the current outbreak, necessitating acute supportive healthcare and airway management.

Vaccination Surge and Recommendations

Public health officials stressed that full vaccination with the two-dose measles, mumps, and rubella (MMR) vaccine delivers 97% lifetime protection. In response to sustained community transmission, DOH recommends that infants aged 6 through 11 months who reside in or visit affected counties receive an early zero dose of the MMR vaccine, which serves as supplementary protection rather than a replacement for the two standard childhood doses.

Demand for immunizations has accelerated sharply throughout the state. Pennsylvania healthcare providers administered more than 61,000 MMR vaccine doses in October and 56,000 doses in September, up from the typical monthly baseline of approximately 25,000 doses, according to state health figures. Additionally, DOH nursing personnel have delivered more than 10,900 doses across the state this year, including over 6,800 doses administered across 241 community pop-up clinics since the outbreak was first identified in late April.